国立研究開発法人 国立成育医療研究センター National Center for Child Health and Development

  • Font--more Large--

Tel: +81-3-3416-0181 / Reservation(Hospital): 03-5494-7300
〈Monday~Friday(except national holiday)9A.M.〜17P.M.〉

  • Access
  • Contact Us
  • MENU

研究者・企業の方へ Scholar & Enterprise

研究者・企業の方へ Scholar & Enterprise

Thesis

氏名:斉藤和幸

主な論文・総説・著書
1 臨床倫理学(訳本)、朝倉書店
2 Hikoichiro M, Takatoshi N, Kazuyuki S, Regulation of traditional herbal medicinal products in Japan. Journal of Ethnopharmacology. 2014;158:511-515.

氏名:森臨太郎

主な論文・総説・著書
1 Vogel JP, Souza JP, Gülmezoglu AM, Mori R, Lumbiganon P, Qureshi Z, Carroli G, Laopaiboon M, Fawole B, Ganchimeg T, Zhang J, Torloni MR, Bohren M, Temmerman M, for the WHO Multi-Country Survey on Maternal and Newborn Health Research Network. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health. The Lancet. 2014;384(9957):1869 - 1877
2 Tobe-Gai R, Mori R, Huang L, Xu L, Han D and Shibuya K. Cost-effectiveness analysis of a national neonatal hearing screening program in China: Universal or targeted strategy? PLoS ONE. 8(1): e51990.
3 Mori R, Ota E, Middleton P, Tobe-Gai R, Mahomed K, Bhutta ZA. Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database of Systematic Reviews 2012;7:CD000230
4 Mori R, Takemi K, and Fineberg H. Science and consensus for health policy making in Japan. Lancet. 2012;379(9810):12-13
5 Mori R, Nardin JM, Yamamoto N, Carroli G and Weeks AD. Umbilical vein injection for the routine management of third stage of labour. Cochrane Database of Systematic Reviews. 2012;3:CD006176.
6 Nagai S, Andrianarimanana D, Rabesandratana N, Yonemoto N, Nakayama T, and Mori R. Long-term Effects of Earlier Initiated Continuous Kangaroo-Mother-Care (KMC) for Low-Birth-Weight (LBW) infants in Madagascar. Acta Paediatrica. 2011;100(12):e241-e247.
7 Mori R, Kusuda S, Fujimura M, on behalf of Neonatal Research Network of Japan. Antenatal corticosteroids promote survival of extremely preterm infants born at 22-23 weeks of gestation. The Journal of Pediatrics. 2011;159(1):110-114.
8 Lumbiganon P, Laopaiboon M, Gülmezoglu AM, Souza JP, Taneepanichskul S, Ruyan P, Attygalle DE, Shrestha N, Mori R, Hinh ND, Bang HT, Rathavy T, Chuyun K, Cheang K, Festin M, Udomprasertgul V, Germar MJV, Yanqui G, Roy M, Carroli G, Ba-Thike K, Filatova E, and Villar J. Mode of delivery and pregnancy outcomes in Asia: The WHO Global Survey on Maternal and Perinatal Health 2007-2008. Lancet. 2010;375(9713):490-499.
9 Mori R, Dougherty M, and Whittle M. An estimation of intrapartum-related perinatal mortality rates for booked home births in England and Wales between 1994 and 2003. BJOG. 2008;115(5):554-559.
10 Mori R, Lakhanpaul M, and Verrier-Jones K. Diagnosis and management of urinary tract infection in children: summary of NICE guidance. BMJ 2007;335:397-397.

氏名:石黒精

主な論文・総説・著書
1 Yotani N, Ishiguro A, Sakai H, et al, Factor-associated caregiver burden in medically complex patients with special health care needs. Pediatr Int 2014;56:742-747.
2 Minowa K, Arai K, Ishiguro A, et al, Romiplostim treatment allows for platelet transfusion-free liver transplantation in pediatric thrombocytopenic patient with primary sclerosing cholangitis. Pediatr Transplant, 2014;18:E212-5.
3 Fujimaru T, Ito S, Ishiguro A, et al, Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange. Cytokine 2014;70:156-60.
4 Maekawa T, Oba M, Ishiguro A, et al, Modified pulmonary index score was sufficiently reliable to assess the severity of acute asthma exacerbations in children. Allergol Int 2014;63:603-607.
5 Ishiguro A, Nakahata T, Matsubara K, et al, Age-related changes in thrombopoietin in children: reference interval for serum thrombopoietin levels. Br J Haematol 1999;106:884-888.
6 Ishiguro A, Ishikita T, Shimbo T, et al, Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease. Thromb Haemost 1999;79:1096-1099.
7 Ishiguro A, Suzuki Y, Inaba Y, et al, Production of interleukin 10 in the cerebrospinal fluid in aseptic meningitis of children. Pediatr Res 1997;40:610-613.
8 Ishiguro A, Spirin K, Shiohara M, et al, Id2 expression increases with myeloid differentiation in human myeloid cells. Blood 1997;87::5225-5230.
9 Nakahata T, Kobayashi T, Ishiguro A, et al, Extensive proliferation of mature connective-tissue type mast cells in vitro. Nature 1986;324:65-67.
10 石黒 精,嶋 緑倫,瀧 正志,他(編),はじめての血友病診療実践マニュアル.東京,診断と治療社,2012.

氏名:中村秀文

主な論文・総説・著書
1 Iijima K, Sako M, Nozu K,,, Nakamura H, et al: Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. The Lancet, 2014;384(9950) October 2014: 1273 - 1281
2 Yoshikawa N, Nakanishi K, Sako M,,, Nakamura H, et al: A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment. Kidney Int 2014 Jul 23. doi: 10.1038/ki.2014.260. [Epub ahead of print]
3 Nakamura H, Ishikawa Y: How do Japanese children take their medicines, and what are pharmacists and paediatricians doing about it? Int. J. of Pharmaceutics. 04/2014; DOI: 10.1016/j.ijpharm.2014.03.053
4 Amstutz U1, Shear NH, Rieder MJ,,, Nakamura H, et al: Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions. Epilepsia 2014; Mar 5. doi: 10.1111/epi.12564. [Epub ahead of print]
5 Iijima K, Sako M, Saito Oba M,,, Nakamura H, et al; Cyclosporine C2 Monitoring for the Treatment of Frequently Relapsing Nephrotic Syndrome in Children:A Multicenter Randomized Phase II Trial. Clinical Journal of the American Society of Nephrology 2014;9(2):1-8
6 Nakamura H, Osawa M, Yokoyama T, et al: Efficacy and safety of levetiracetam as adjunctive therapy in Japanese children with uncontrolled partial-onset seizures: multicenter and open-label study (N01223), short term evaluation. Brain Nerve 2013 ; Sep;65(9):1083-92
7 Nakamura H, Kawashima H, Azuma R, et al: Pharmacokinetics of the H2 Blocker Roxatidine acetate Hydrochloride in Pediatric Patients,inComparison with Healthy Adult Volunteers. Drug Metab.Pharmacokinet 2012;27(4):422-429
8 Nakamura H, Ono S: Japanese Perspective. PEDIATRIC DRUG DEVELOPMENT Concepts and Applications, WILEY-BLACKWELL.2011:153-164
9 中村秀文: 薬物投与の基本的考え方. 編集 五十嵐隆. 小児科学改訂. 第10版. 東京. 文光堂. 2011; 1067-1080
10 Nakamura H : Current situation and critical points for peadiatric research in Japan. Innovative Medicine. The Science and the Regulatory Framework. Pharmaceuticals Policy AND Law. 2010;12:117-124

氏名:中川聡

主な論文・総説・著書
1 Imai Y, Nakagawa S, Ito Y, Kawano T, Slutsky AS, Miyasaka K. Comparison of lung protection strategies using conventional and high-frequency oscillatory ventilation. J Appl Physiol 91:1836-1844, 2001.
2 Trachsel D, McCrindle, Nakagawa S, Bohn D. Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure. Am J Respir Crit Care Med 172:206-211, 2005.
3 Kitano Y, Nakagawa S, Kuroda T, et al. Liver position in fetal congenital diaphragmatic hernia retains a prognostic value in the era of lung-protective strategy. J Pediatr Surg 40:1827-32; 2005.
4 Okumura A, Nakagawa S, Kawashima H, et al. Deaths associated with pandemic (H1N1) 2009 among children, Japan, 2009-2010. Emerging Infectious Diseases 2011; 17:1993-2000.
5 Imamura T, Nakagawa S, Goldman RD, Fujiwara T. Validation of pediatric index of mortality 2 (PIM2) in a single pediatric intensive care unit in Japan. Intensive Care Med 2012; 38:649-654.
6 Tokuhira N, Shime N, Inoue M, Kawasaki T, Sakurai Y, Kurosaka N, Ueta I, Nakagawa S. Mechanically ventilated children with 2009 pandemic influenza A/H1N1, Results from the national pediatric intensive care registry in Japan. Pediatr Crit Care Med 2012; 13:E294-98.
7 Takeda S, Kotani T, Nakagawa S, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) severe respiratory failure in Japan. J Anesth 2012; 26:650-57.
8 Shime N, Kawasaki T, Saito O, Akamine Y, Toda Y, Takeuchi M, Sugimura H, Sakurai Y, Iijima M, Ueta I, Shimizu N, Nakagawa S. Incidence and risk factors for mortality in paediatric severe sepsis, results from national paediatric intensive care registry in Japan. Intensive Care Med 2012; 38:1191-97.
9 Nakagawa S, Shime N. Respiratory rate criteria for pediatric systemic inflammatory response syndrome. Pediatr Crit Care Med 2014; 15:182.
10 中川 聡.HFOと肺損傷予防.In 中川 聡編.HFOV(高頻度振動換気法)のすべて.東京.日刊工業新聞社2010;1-20. 中川 聡.小児医療におけるHFO.In 中川 聡編.HFOV(高頻度振動換気法)のすべて.東京.日刊工業新聞社2010;74-93.

氏名:小林 徹

主な論文・総説・著書
1 Kobayashi T, Kobayashi T, Morikawa A, Ikeda K, Seki M, Shimoyama S, Ishii Y, Suzuki T, Nakajima K, Sakamoto N, Arakawa H. Efficacy of intravenous immunoglobulin combined with prednisolone for resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease. J Pediatr. 2013:163(2):521-6
2 Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa S, Miura M, Nomura Y, Fuse S, Ichida F, Seki M, Fukazawa R, Ogawa C, Furuno K, Tokunaga H, Takatsuki S, Hara S, Morikawa A, RAISE Study Group Investigators. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease: a prospective, randomised, open, blinded-endpoint trial. LANCET, 2012;379:1613-1620.
3 Kobayashi T, Inoue Y, Otani T, Morikawa A, Kobayashi T, Takeuchi K, Saji T, Sonobe T, Ogawa S, Miura M, Arakawa H. Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy for Kawasaki disease. Pediatr Infect Dis J. 2009;28:498-502.
4 Kobayashi T, Kimura H, Okada Y, Inoue Y, Kobayashi T, Shinohara M, Morikawa A. Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease. Clin Exp Immunol. 2007; 148:112-118.
5 Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006; 113:2606-2612.
6 Hirai K, Tabata H, Hirayama M, Kobayashi T, Oh T, Mochizuki H. A new method for objectively evaluating childhood nocturnal cough. Pediatr Pulmonol. 2015 in press.
7 Ogata S, Tremoulet AH, Sato Y, Ueda K, Shimizu C, Sun X, Jain S, Silverstein L, Baker AL, Tanaka N, Ogihara Y, Ikehara S, Takatsuki S, Sakamoto N, Kobayashi T, Fuse S, Matsubara T, Ishii M, Saji T, Newburger JW, Burns JC. Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol. 2013;168:3825-8
8 Shiba N, Ichikawa H, Taki T, Park MJ, Jo A, Mitani S, Kobayashi T, Shimada A, Sotomatsu M, Arakawa H, Adachi S, Tawa A, Horibe K, Tsuchida M, Hanada R, Tsukimoto I, Hayashi Y. NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia. Genes Chromosomes Cancer. 2013 Jul;52(7):683-93.
9 Fuse S, Kobayashi T, Arakaki Y, Ogawa S, Katoh H, Sakamoto N, Hamaoka, Saji T. Standard method for ultrasound imaging of coronary artery in children. Pediatr Int, 2010;52:876-882
10 Kanai T, Ishiwata T, Kobayashi T, Sato H, Takizawa M, Kawamura Y, Tsujimoto H, Nakatani K, Ishibashi N, Nishiyama M, Hatai Y, Asao Y, Kobayashi T, Takeshita S, Nonoyama S. Ulinastatin, a urinary trypsin inhibitor, for the initial treatment of patients with Kawasaki disease. Circulaion 2011;124:2822-2828.

氏名:阿部 浩之

主な論文・総説・著書
1 Abe H, Morikawa R, Otsuka M. Adsorption kinetic and mechanistic studies for pharmaceutical spherical carbon adsorbents: comparison of a brand product and two generics. Colloids Surf B Biointerfaces, 103, 538-43 (2013).
2 Otsuka Y, Yamamoto M, Abe H, Otsuka M. Effects of polymorphic transformation on pharmaceutical properties of direct compressed tablets containing theophylline anhydrate bulk powder under high humidity. Colloids Surf B Biointerfaces, 102, 931-6 (2012).
3 Abe H, Otsuka M. Comparison of physico-chemical characteristics among three pharmaceutical spherical carbon adsorbents. Colloids Surf B Biointerfaces, 100, 90-4 (2012).
4 Teraoka R, Abe H, Sugama T, Ito K, Aburada M, Otsuka M. Nondestructive prediction of oren extract powder, a herbal medicine, in suppositories by chemometric near-infrared spectroscopy. J Nat Med, 66, 329-32 (2012).
5 Abe H, Otsuka M. Effects of lubricant-mixing time on prolongation of dissolution time and its prediction by measuring near infrared spectra from tablets. Drug Dev Ind Pharm, 38, 412-9 (2012).
6 Sakurai M, Abe H, Okamura N, Inoue Y, Akiyoshi T, Matsuyama K, Uchida T, Otsuka M. Stability of gabexate mesilate products: Influence of the addition of mannitol. Biomed Mater Eng, 20, 13-20 (2010).
7 Otsuka E, Abe H, Aburada M, Otsuka M. Nondestructive prediction of the drug content of an aspirin suppository by near-infrared spectroscopy. Drug Dev Ind Pharm, 36, 839-44 (2010).

氏名:佐古まゆみ

主な論文・総説・著書
1 Ishikura K, Matsumoto S, Sako M, et al: Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. Clin Exp Nephrol, 2015 ;19(1):6-33.
2 Kaku Y, Ohtsuka Y, Sako M, et al: Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy. Clin Exp Nephrol, 2015 ;19(1):34-53.
3 Igarashi T, Ito S, Sako M, et al: Guidelines for the management and investigation of hemolytic uremic syndrome. Clin Exp Nephrol, 2014; 18(4): 525-557.
4 Iijima K, Sako M, Nozu K, et al: Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group: Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.  Lancet 2014;4:1273-1281.
5 Yoshikawa N,Nakanishi K,Sako M,et al: A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment.  Kidney Int 2014 Jul 23. doi: 10.1038/ki.2014.260. [Epub ahead of print]
6 Iijima K, Sako M, Oba MS, et al: Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial. Clin J Am Soc Nephrol 2014;9:271-278.
7 Sako M, Nakanishi K, Obana M, et al: Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney Int 2005 ;67:1248-1255.

氏名:栗山 猛

主な論文・総説・著書
1 栗山猛,松井陽.未承認薬を減らす小児治験ネットワーク-より有効でより安全な医薬品を子どもたちへ.医学のあゆみ.2011;238(2),201-207.
2 栗山猛.小児医薬品開発の推進-小児治験ネットワークの構築・稼働-.医薬品医療機器レギュラトリーサイエンス2012;43(2):98-103
3 栗山猛.現場発の小児医薬品開発-より有効でより安全な医薬品を子どもたちへ-.一般財団法人日本医薬情報センターJAPIC NEWS.2013.10;354:12-13

氏名:田島 康則

主な論文・総説・著書
1 田島康則:治験実施計画書からの逸脱、被験者の選定について,薬理と治療,2015;43(6):744-747

氏名:矢作 尚久

主な論文・総説・著書
1 Kojima K, Ishihara J, Yahagi N, Predicting outcomes of neonates born to GBS positive women who received inadequate intrapartum antimicrobial prophylaxis. The Turkish Journal of Pediatrics. 2014;56(3):238-42.
2 Yahagi N, New strategy for clinical research: approach for value based medicine. The Journal of Pediatric Practice. 2014;77(5):661-668.
3 Yahagi N, Overview of innovative healthcare management system in clinical research. New Medicine in Japan. 2014; 41(3):45-48.
4 Yahagi N, The Global strategy for medical management. Medical Science Review 2011; 28: 31-62.
5 Yahagi N, A strategy for triage management reform: Toward a value-based system. The Japanese Journal of Acute Medicine. 2010 Sep; 34(9):1011-1014.

氏名:瀧本哲也

主な論文・総説・著書
1 Tsurusawa M, Gosho M, Mori T, et al. Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood non Hodgkin lymphoma.  Pediatr Blood Cancer 2014 (in press).
2 Limin Yang, Tetsuya Takimoto and Junichiro Fujimoto. Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma. BMC Cancer 2014;14:654-660.
3 Ryoji Kobayashi, Tetsuya Takimoto, Atsuko Nakazawa, et al : Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols. Int J Hematol 2014;99:743-749.
4 Masahito Tsurusawa, Tetsuya Mori, Akira Kikuchi, et al. Improved treatment results of children with B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study. Pediatr Blood Cancer 2014;61:1215-1221.
5 Tatsuo Kuroda, Ken Hoshino, Shunsuke Nosaka, et al. Critical hepatic hemangiomas in infants: from the results of a recent nationwide survey in Japan. Pediatr Int 2014;56:304-308.
6 Keizo Horibe, Akiko M Saito, Tetsuya Takimoto, et al. Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology.  Int J Hematol 2013;98:74-88.
7 森 鉄也, 深野玲司, 齋藤明子, 他.小児未分化大細胞型リンパ腫に対するランダム化国際臨床試験ALCL99-R1国内登録例の解析.   臨血 2014;55:526-33.
8 副島俊典,正木栄一,原純一,他.小児がん診療に関する放射線治療の実態調査.  日小児血がん会誌 2014;51:9-13.
9 佐藤聡美,瀧本哲也.小児がん経験者の認知機能アセスメント.  日小児血がん会誌 2013;50:386-391.
10 瀧本哲也,池田 均.日本小児がん学会と日本神経芽腫研究グループの登録データからみた本邦の神経芽腫実態把握の現況.日小児血がん会誌 2012;49:304-309.

氏名:加藤 承彦

主な論文・総説・著書
1 Kato, T., Yorifuji, T., Yamakawa, M., Inoue, S., Saito, K., Doi, H., and Kawachi, I. (2015). Association of Breastfeeding with Early Childhood Dental Caries: Japanese Population-based Study, BMJ Open, 2015 Mar 20;5(3):e006982.
2 Yamakawa, M., Yorifuji, T., Kato, T., Inoue, S., and Tsuda, T. (2015). Long-term Effects of Breastfeeding on Children's Hospitalization for Respiratory Tract Infections and Diarrhea in early childhood in Japan, Maternal and Child Health Journal, Feb 6.
3 Yamakawa, M., Yorifuji, T., Kato, T., Yamauchi, Y., and Doi, H. (2014). Breastfeeding and Hospitalization for Asthma in Early Childhood: A Nationwide Longitudinal Survey in Japan, Public Health Nutrition, Nov 6:1-6.
4 Yorifuji, T., Kato, T., Tokibnobu, A., Yamakawa, M., Tsuda, T., and Sanada, S. (2014). Intrauterine Exposure to Methylmercury and Neurocognitive Functions-Minamata Disease, Archives of Environmental and Occupational Health, June 27:0.
5 Yorifuji, T., Kubo, T., Yamakawa, M., Kato, T., Inoue, S., and Doi, H. (2014). Breastfeeding and Behavioral Development: A Nationwide Longitudinal Survey in Japan, Journal of Pediatrics, 164(5), 1019-1025.
6 Kato, T., Yorifuji, T., Inoue, S., Yamakawa, M., Doi, H., and Kawachi, I. (2013). Preterm Births and Child Health and Development: Japanese Population-based Study, Journal of Pediatrics, 163(6), 1578-1584.
7 Yorifuji, T., Kashima, S., Tokinobu, A., Kato, T., and Tsuda, T. (2013). Regional impact of exposure to a polychlorinated biphenyls and polychlorinated dibenzofurans mixture from contaminated rice oil on stillbirth rate and secondary sex ratio, Environment International, 59, 12-15.
8 Kato, T., Yorifuji, T., Inoue, S., Doi, H., and Kawachi, I. (2013). Association of Birth Length and Risk of Hospitalization among Full-term Babies in Japan, Paediatric and Perinatal Epidemiology, 27(4), 361-70.
9 Yamakawa, M., Yorifuji, Y., Inoue, S., Kato, T., and Doi, H. (2013). Breastfeeding and Obesity among Schoolchildren: A Nationwide Longitudinal Survey in Japan, JAMA Pediatrics, 167(10): 919-925.
10 Yorifuji, T., Naruse, H., Kashima, S., Murakoshi, T., Kato, T., Inoue, S., Doi, H., and Kawachi, I. (2012). Trends of Preterm birth and Low Birth Weight in Japan: Contribution of Obstetrical Intervention, BMC Pregnancy and Childbirth, 12, 162.

氏名:森崎 菜穂

主な論文・総説・著書
1 Morisaki N, Ganchimeg T, Ota E, Vogel J, Souza JP, Mori R, Gulmezoglu A. Maternal and institutional characteristics associated with administering prophylactic antibiotics in cesarean delivery British Journal of Obstetrics and Gynecology 2014 Mar;121 Suppl 1:66-75
2 Morisaki N, Ganchimeg T, Vogel J, Cecatti J, Barrett J, Jayaratne K, Mittal S, Ortiz-Panozo E, Souza JP, Crowther C, Ota E, Mori R. Mode and timing of twin delivery and perinatal outcomes in low- and middle-income countries: Secondary analysis of the WHO Multi- country Survey on Maternal and Newborn Health British Journal of Obstetrics and Gynecology 2014 Mar;121 Suppl 1:89-100
3 Morisaki N, Ganchimeg T, Ota E, Vogel J, Souza JP, Hogue C, Jayaratne K, Mori R. Risk factors for spontaneous and provider-initiated preterm delivery in high and low Human Development Index countries: secondary analysis of the WHO Multi- country Survey on Maternal and Newborn Health British Journal of Obstetrics and Gynecology 2014 Mar;121 Suppl 1:101-9
4 Morisaki N, Belfort MB, Mori R, Kusuda S, Fujimura M. Brief Parenteral Nutrition Accelerates Weight Gain, Head Growth even in Healthy VLBWs. PLoS One. 2014 Feb 19;9(2):
5 Morisaki N, Esplin MS, Varner MW, Henry E, Oken E. Declines in birth weight and fetal growth independent of gestational length. Obstetrics and Gynecology. 2013 Jan;121(1):51-8
6 Ganchimeg T, Ota E, Morisaki N, Lumbiganon P, Laopaiboon M, Zhang JJ, Yadamsuren B, Temmerman M, Say L, Tuncalp O, Vogel J , Souza JP, Mori R. Pregnancy and childbirth outcomes among adolescent mothers: a WHO multi-country study British Journal of Obstetrics and Gynecology 2014 Mar;121 Suppl 1:40-8.
7 Vogel J, Betrán AP, Vindevoghel N, Souza JP, Torloni MR, Zhang J, Tunçalp Ö, Mori R, Morisaki N, Ortiz-Panozo E, Hernandez B, Pérez-Cuevas R, Qureshi Z, Gülmezoglu AM, Temmerman M. Use of the Robson classification to assess caesarean section trends in 21 countries: a secondary analysis of two WHO multicountry surveys. Lancet Global Health 2015
8 Pileggi C, Camelo J Jr., Perdoná G, Mussi-Pinhata M, Cecatti J, Mori R, Morisaki N, Yunis K, Vogel J, Tuncalp O, Souza JP. Development of criteria for identifying neonatal near miss cases: analysis of two WHO multi-country cross sectional studies. British Journal of Obstetrics and Gynecology 2014 Mar;121 Suppl 1:110-8.
9 Vogel J, Souza JP, Mori R, Morisaki N, Lumbiganon P, Laopaiboon M, Ortiz-Panozo E, Hernández-Prado B, Perez-Cuevas R, Roy M, Mittal S, Cecatti J, Tuncalp O, Gulmezoglu A. Maternal complications and perinatal mortality: findings of the World Health Organization Multi-country Survey on Maternal and Newborn Health. British Journal of Obstetrics and Gynecology 2014 Mar;121 Suppl 1:76-88
10 Hasumi E, Iwata H, Kohro T, Manabe I, Kinugawa K, Morisaki N, Ando J, Sawaki D, Takahashi M, Fujita H, Yamashita H, Ako J, Hirata Y, Komuro I, Nagai R. Diagnostic implication of change in b-type natriuretic peptide (BNP) for prediction of subsequent target lesion revascularization following silorimus-eluting stent deployment. International Journal of Cardiolology. 2013 Sep 30;168(2):1429-34.

氏名:掛江 直子

主な論文・総説・著書
1 Chieko Kurihara, Hideo Kusuoka, Shunsuke Ono, Naoko Kakee, et al: High Rate of Awarding Compensation for Claims of Injuries Related to Clinical Trials by Pharmaceutical Companies in Japan. PLOS ONE 2014; 9(1): e84998.
2 Naoko Tsuji, Naoko Kakee, Yasushi Ishida, et al: Validation of the Japanese version of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module. Health and Quality of Life Outcomes 2011, 9:22. doi: 10.1186/1477-7525-9-22.
3 掛江直子: 海外における新生児・小児の治療の差し控え・中止のガイドライン. 船戸正久編. 新生児・小児医療かかわる人のための看取りの医療. 診断と治療社, 2010: 150-158.
4 掛江直子: 日本における治療の差し控え・中止のガイドライン. 船戸正久編. 新生児・小児医療かかわる人のための看取りの医療. 診断と治療社, 2010: 159-170.
5 Yasushi Ishida, Naoko Sakamoto, Kiyoko Kamibeppu, Naoko Kakee, et al: Late effects and quality of life of childhood cancer survivors: Part 2. Impact of radiotherapy. Int. J Hematol 2010; 92: 95-104.
6 Fujii C, Sato Y, Harada S, Kakee N, et al: M. Attitude to extended use and long-term storage of newborn screening blood spots in Japan. Pediatr Int 2010; 52(3): 393-397.
7 掛江直子: 臨床試験に参加する患児の人権保護(研究倫理). 五十嵐隆・菊池陽編. 小児科臨床ピクシス10. 小児白血病診療, 中山書店, 2009: 176-179.
8 掛江直子, 田中英高, 星井桜子, 他: 小児脳死臓器移植に関するアンケート調査-日本小児科学会会員に対する意識調査2007-. 日本小児科学会雑誌 2009; 113(7): 1181-1193.
9 Hirokazu Sato, Nobue Nakamura, Shohei Harada, Naoko Kakee, et al: Quality of life of young adults with congenital hypothyroidism; Pediatrics International 2009; 51:126-131.
10 掛江直子: 再生医療における倫理的・法的・社会的問題. 綜合臨牀 2009; 58(1) :27-32.

氏名:大田えりか

主な論文・総説・著書
1 Ota E, Haruna M, Suzuki M, Anh DD, Tho HL,Thanh Tam NT, Thiem VD, Hien Anh NT, Isozaki M, Shibuya K, Ariyoshi K, Murashima S, Moriuchi H, Yanai H.The association of gestational weight gain and maternal body mass index on perinatal outcomes in Vietnamese women. Bulletin of the World Health Organization.2011: 89(2):127-136.
2 Ota E, Wariki WMV, Mori R, Hori N, Shibuya K. Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in high-income countries. Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD006045. DOI: 10.1002/14651858.CD006045.pub3.
3 Ota E, Souza JP, Tobe-Gai R, Mori R, Middleton P, Flenady V. Interventions during the antenatal period for preventing stillbirth: an overview of Cochrane systematic reviews (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 1. Art. No.: CD009599. DOI: 10.1002/14651858.CD009599.
4 Ota E, Tobe-Gai R, Mori R, Farrar D. Antenatal dietary advice and supplementation to increase energy and protein intake. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD000032. DOI: 10.1002/14651858.CD000032.pub2.
5 Ota E, Ganchimeg T, Morisaki N, Vogel JP, Pileggi C, et al. Risk Factors and Adverse Perinatal Outcomes among Term and Preterm Infants Born Small-for-Gestational-Age: Secondary Analyses of the WHO Multi-Country Survey on Maternal and Newborn Health. PLoS ONE 2014; 9(8): e105155. doi:10.1371/journal.pone.0105155.
6 Ota E, Haruna M, Yanai H, Suzuki M, Dang DA, Matsuzaki M, Tho LH, Ariyoshi K, Yeo SA and Murashima S. Reliability and Validity of the Vietnamese version of the pregnancy physical activity questionnaire (PPAQ).The Southeast Asian Journal of Tropical Medicine and Public Health 2008; 39(3) 562-570.
7 Ota E, Haruna M, Matsuzaki M, Honda Y, Sasaki S, Yeo SA, Murashima S. Comparison of body fat mass changes during the third trimester and at one month postpartum between lactating and nonlactating Japanese women. BioScience Trends 2008; 2(5): 200-205.
8 Ota E, Mori R, Middleton P, Tobe-Gai R, Mahomed K, Miyazaki C, Bhutta ZA. Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database of Systematic Reviews 2015, Issue 2. Art. No.: CD000230. DOI: 10.1002/14651858.CD000230.pub5.
9 Ganchimeg T, Ota E, Morisaki N, Laopaiboon M, Lumbiganon P, Zhang J, Yamdamsuren B, Temmerman M, Say L, Tunc alp O, Vogel JP, Souza JP, Mori R, on behalf of the WHO Multicountry Survey on Maternal Newborn Health Research Network. Pregnancy and childbirth outcomes among adolescent mothers: a World Health Organization multicountry study. BJOG 2014; 121 (Suppl. 1): 40–48.
10 Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk Factors of Pre-Eclampsia/Eclampsia and Its Adverse Outcomes in Low- and Middle-Income Countries: A WHO Secondary Analysis. PLoS ONE 2014;9(3): e91198. doi:10.1371/journal.pone.0091198.

氏名:蓋 若琰(がいじゃくえん)

主な論文・総説・著書
1 Tobe RG, Mori R, Huang L, et al. Cost-effectiveness analysis of a national neonatal hearing screening program in China: conditions for the scale-up. PLoS ONE.2013; 8: e51990.
2 Tobe RG, Mori R. Use of multiple micronutrient powders for young children’s growth. The Lancet. 2013;382:1171-2.
3 馬進、任苒、蓋若琰.国家卫生和计划生育委员会“十二五”规划教材编辑委员会编 「国際衛生保健」,人民卫生出版社,2013年8月.
4 Zhou C, Tobe RG, Chu J, Geng H, Wang X, Xu L. Detection delay of pulmonary tuberculosis patients among migrants in China: a cross-sectional study. International Journal of Tuberculosis and Lung Diseases 2012; 16: 1630-6.
5 Huang L, Zhang L, Tobe RG, et al. Cost-effectiveness analysis of neonatal hearing screening program in China: should universal screening be prioritized? BMC Health Services Research. 2012; 12: 97.
6 Song P, Tobe RG, Inagaki Y, et al. The management of hepatocellular carcinoma around the world: A comparison of guidelines from 2001 to 2011. Liver Interventional. 2012; 32: 1053-63.
7 Ota E, Tobe-Gai R, Mori R, Farrar D. Antenatal dietary advice and supplementation to increase energy and protein intake. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD000032. DOI: 10.1002/14651858.CD000032.pub2.
8 Tobe RG, Mori R, Shinozuka N, et al Birthweight discordance, risk factors and its impact on perinatal mortality among Japanese twins: data from a national project during 2001-2005. Twin Research and Human Genetics 2010; 13: 490-4.
9 Tobe RG, Mori R, Shinozuka N, et al. A nationwide investigation on gestational age specific birthweight and discharge mortality among Japanese twins in general hospitals. Paediatrics and Perinatal Epidemiology. 2010; 25: 228-35.
10 Gai R, Xu L, Zhu M, et al. Health resource allocation and productive efficiency of Chinese county hospitals: Data from 1993 to 2005. BioScience Trends. 2010; 4: 218-24.

氏名:永田知映

主な論文・総説・著書
1 Nagata C., Tanabe H., Takakura S., Narui C., Saito M., Yanaihara N. & Okamoto A. 2015. Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic malignancy. J Obstet Gynaecol Res, (forthcoming)
2 Yanaihara N., Hirata Y., Yamaguchi N., Noguchi Y., Saito M., Nagata C., Takakura S., Yamada K. & Okamoto A. 2015. Antitumor Effects of Interleukin-6 (Il-6)/Interleukin-6 Receptor (Il-6r) Signaling Pathway Inhibition in Clear Cell Carcinoma of the Ovary. Mol Carcinog, (forthcoming)
3 Suzuki K., Takakura S., Saito M., Morikawa A., Suzuki J., Takahashi K., Nagata C., Yanaihara, N., Tanabe, H. & Okamoto, A. 2014. Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary. Int J Gynecol Cancer, 24, 1181-9.
4 Sasaki T., Nishi H., Nagata C., Nagai T., Nagao T., Terauchi F. & Isaka K. 2013. A retrospective study of urokinase-type plasminogen activator receptor (uPAR) as a prognostic factor in cancer of the uterine cervix. Int J Clin Oncol, 19, 1059-64.
5 Nagata, C., Yanagida, S., Okamoto, A., Morikawa, A., Sugimoto, K., Okamoto, S., Ochiai, K. & Tanaka, T. 2012. Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest. J Obstet Gynaecol Res, 38, 639-44.
6 Yanaihara, N., Anglesio, M. S., Ochiai, K., Hirata, Y., Saito, M., Nagata, C., Iida, Y., Takakura, S., Yamada, K., Tanaka, T. & Okamoto, A. 2012. Cytokine gene expression signature in ovarian clear cell carcinoma. Int J Oncol, 41, 1094-100.
7 Yamada, K., Tanabe, H., Imai, M., Jobo, T., Kudo, K., Fujiwara, H., Nagata, C., Furuya, K., Suzuki, M., Ochiai, K., Tanaka, T. & Yasuda, M. 2013. Feasibility study of paclitaxel plus carboplatin in patients with endometrial cancer: a Japan Kanto Tumor Board study (JKTB trial). J Obstet Gynaecol Res, 39, 311-6.
8 Kunito, S., Takakura, S., Nagata, C., Saito, M., Yanaihara, N., Yamada, K., Okamoto, A., Sasaki, H., Ochiai, K. & Tanaka, T. 2012. Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line chemotherapy. J Obstet Gynaecol Res, 38, 1367-75.
9 Ueda, K., Yamada, K., Kiyokawa, T., Iida, Y., Nagata, C., Hamada, T., Saito, M., Aoki, K., Yanaihara, N., Takakura, S., Okamoto, A., Ochiai, K.,Ohkawa, K. & Tanaka, T. 2012. Pilot study of CD147 protein expression in epithelial ovarian cancer using monoclonal antibody 12C3. J Obstet Gynaecol Res, 38, 1211-9.
10 永田知映, 他. 神田英一郎監訳:初心者のためのロジスティック回帰分析入門. 丸善出版株式会社, 東京, 2012. P33-59.